AAAAAA

   
Results: 1-7 |
Results: 7
Interferon-beta (IFN-beta) antibodies in interferon-beta 1a-and interferon-beta 1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo
Authors: Perini, P Facchinetti, A Bulian, P Massaro, AR De Pascalis, D Bertolotto, A Biasi, G Gallo, P
Citation: P. Perini et al., Interferon-beta (IFN-beta) antibodies in interferon-beta 1a-and interferon-beta 1b-treated multiple sclerosis patients. Prevalence, kinetics, cross-reactivity, and factors enhancing interferon-beta immunogenicity in vivo, EUR CYTOKIN, 12(1), 2001, pp. 56-61
The HLA-DR13 haplotype is associated with "benign" multiple sclerosis in northeast Italy
Authors: Perini, P Tagliaferri, C Belloni, M Biasi, G Gallo, P
Citation: P. Perini et al., The HLA-DR13 haplotype is associated with "benign" multiple sclerosis in northeast Italy, NEUROLOGY, 57(1), 2001, pp. 158-159
Interleukin-1 receptor antagonist, soluble tumor necrosis factor-a receptor type I and II and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta 1a
Authors: Perini, P Tiberio, M Sivieri, S Facchinetti, A Biasi, G Gallo, P
Citation: P. Perini et al., Interleukin-1 receptor antagonist, soluble tumor necrosis factor-a receptor type I and II and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta 1a, EUR CYTOKIN, 11(1), 2000, pp. 81-85
Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome
Authors: De Stefano, R Selvi, E Villanova, M Frati, E Manganelli, S Franceschini, E Biasi, G Marcolongo, R
Citation: R. De Stefano et al., Image analysis quantification of substance P immunoreactivity in the trapezius muscle of patients with fibromyalgia and myofascial pain syndrome, J RHEUMATOL, 27(12), 2000, pp. 2906-2910
Effect of IFN beta and anti-IFN beta antibodies on NK cells in multiple sclerosis patients
Authors: Perini, P Wadhwa, M Buttarello, M Meager, A Faccinetti, A Thorpe, R Biasi, G Gallo, P
Citation: P. Perini et al., Effect of IFN beta and anti-IFN beta antibodies on NK cells in multiple sclerosis patients, J NEUROIMM, 105(1), 2000, pp. 91-95
A meta-analysis of the tolerability of amtolmetin guacil, a novel, effective nonsteroidal anti-inflammatory drug, compared with established agents
Authors: Marcolongo, R Frediani, B Biasi, G Minari, C Barreca, C
Citation: R. Marcolongo et al., A meta-analysis of the tolerability of amtolmetin guacil, a novel, effective nonsteroidal anti-inflammatory drug, compared with established agents, CLIN DRUG I, 17(2), 1999, pp. 89-96
Percutaneous stenting of the internal carotid artery: The European CAST I study
Authors: Bergeron, P Becquemin, JP Jausseran, JM Biasi, G Cardon, JM Castellani, L Martinez, R Fiorani, P Kniemeyer, P
Citation: P. Bergeron et al., Percutaneous stenting of the internal carotid artery: The European CAST I study, J ENDOVAS S, 6(2), 1999, pp. 155-159
Risultati: 1-7 |